SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-206202
Filing Date
2023-08-08
Accepted
2023-08-08 16:08:46
Documents
15
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d530858d8k.htm   iXBRL 8-K 27537
2 EX-99.1 d530858dex991.htm EX-99.1 81963
7 GRAPHIC g530858dsp1.jpg GRAPHIC 3436
  Complete submission text file 0001193125-23-206202.txt   290189

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eftr-20230808.xsd EX-101.SCH 4334
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftr-20230808_def.xml EX-101.DEF 14094
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftr-20230808_lab.xml EX-101.LAB 23583
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftr-20230808_pre.xml EX-101.PRE 15127
9 EXTRACTED XBRL INSTANCE DOCUMENT d530858d8k_htm.xml XML 5585
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 231151322
SIC: 2834 Pharmaceutical Preparations